Skip to content

Malignant Transformation Risk & Monitoring

Last updated:

The lifetime risk of multiple osteochondromas becoming cancerous (malignant transformation) is 1% to 10%. While most bumps remain benign, it is crucial to monitor for red flags like new pain or rapid growth, especially in adults. MRI is the gold standard for evaluating suspicious changes.

Key Takeaways

  • The vast majority of osteochondromas remain benign throughout a person's life, with only a 1% to 10% lifetime risk of becoming cancerous.
  • A cartilage cap thicker than 1.5 to 2 cm in an adult is a key warning sign that requires further evaluation.
  • Bumps on the pelvis, hips, or shoulders carry a higher risk of malignant transformation than those on the hands or feet.
  • New or deep pain, especially at night, or sudden growth after reaching skeletal maturity are red flags that warrant immediate medical attention.
  • Regular physical exams and MRI scans are the gold standard for monitoring changes and catching potential malignancies early.

For many families living with Multiple Osteochondromas, the risk of “malignant transformation”—a benign bump becoming cancerous—is the most stressful part of the diagnosis. While this is a serious topic, it is important to lead with the facts: The vast majority of osteochondromas will remain benign for a person’s entire life [1][2].

By understanding what to look for and how doctors monitor these changes, you can move from a state of constant worry to a state of proactive care. (If you haven’t yet, read about Building Your Care Team to ensure you have the right experts).

Benign vs. Malignant: What’s the Difference?

Most bumps are benign (non-cancerous). They may cause pain or limit movement, but they do not spread to other parts of the body [1]. A malignant change occurs when the cells in the bump’s “cartilage cap” begin to grow uncontrollably, becoming a type of bone cancer called secondary peripheral chondrosarcoma [2][3].

The Cartilage Cap

Every osteochondroma has a “cap” made of cartilage, similar to the cap on a mushroom [2].

  • In Children: The cap is naturally thicker (sometimes up to 3 cm) because the child is still growing [4].
  • In Adults: Once growth stops, the cap should thin out. A cap that remains thicker than 1.5 to 2 cm in an adult is a signal for doctors to look more closely [5][4].

Understanding the Risk

The lifetime risk of this transformation is estimated to be between 1% and 10% [2][6]. While this is higher than the risk for a person with only a single bone bump (about 1%), it still means that 90% or more of people with this condition will never face a malignant change [3][2].

Who is most at risk?

  • Age: Transformation is very rare in young children. The “highest risk” window is typically between the ages of 20 and 40 [3][6].
  • Location: Bumps located on the “flat” bones of the pelvis, hips, or shoulders are statistically more likely to undergo this change than bumps on the hands or feet [3][7].

Clinical “Red Flags”

Monitoring doesn’t always require expensive scans; your own observations are the most powerful tool. You should contact your orthopedic specialist if you notice:

  1. New Pain: A deep, persistent ache in a bump that was previously painless, especially if it hurts at night [2][4].
  2. New Growth: A bump that starts growing again after the child has finished puberty and reached “skeletal maturity” [4][8].
  3. Rapid Change: Any bump that noticeably increases in size over a short period (weeks or months) [2].

How Monitoring Works

The goal of monitoring is to catch changes early, when they are highly treatable.

  • The Timeline: During childhood, doctors typically recommend an annual or semi-annual physical exam with X-rays as needed to monitor growth [1]. Once a patient reaches adulthood, a baseline MRI is often discussed, followed by exams every 1 to 2 years, or immediately if any “red flags” appear [2][9].
  • Physical Exams: Regular check-ups with an orthopedic specialist allow them to “map” the bumps and check for changes in size or tenderness [1].
  • MRI Scans: This is the “gold standard” for looking at the cartilage cap. An MRI provides a clear picture of how thick the cap is and whether it looks organized or suspicious [2][5].
  • Low-Dose CT: Occasionally used to get a better look at the bone structure itself [10].

A Note of Reassurance: Even if a transformation is found, secondary chondrosarcomas in this condition are often “low-grade,” meaning they tend to grow slowly and are often cured through surgical removal [11]. Regular monitoring is the key to ensuring the best possible outcome.

Frequently Asked Questions

What are the signs an osteochondroma is becoming cancerous?
Warning signs include a new, deep, persistent ache that may hurt at night, a bump that starts growing again after you have stopped growing, or any bump that increases in size rapidly over a few weeks or months.
How common is it for multiple osteochondromas to turn into cancer?
The lifetime risk of an osteochondroma transforming into a malignant tumor is between 1% and 10%. This means the vast majority of people with this condition will never experience a malignant change.
What is the cartilage cap and why is it important?
Every osteochondroma has a cartilage cap. In adults, a cap that remains thicker than 1.5 to 2 centimeters is suspicious and requires closer medical evaluation, usually with an MRI, to check for malignant changes.
Which osteochondromas are most at risk for becoming malignant?
Bumps located on flat bones like the pelvis, hips, or shoulders have a higher risk of malignant transformation compared to bumps on the hands or feet. The risk is also highest for adults between the ages of 20 and 40.
How should adults with multiple osteochondromas be monitored?
Adults typically get a baseline MRI to evaluate their bone bumps. Following this, orthopedic specialists usually recommend physical exams every 1 to 2 years, or immediately if any new pain or rapid growth occurs.

Questions for Your Doctor

  • Based on my child's current age and bone maturity, how often should we be doing physical exams to check for changes?
  • Are any of the current bumps in 'high-risk' locations like the pelvis or hip that we should monitor more closely?
  • If we notice a new pain, what is the process for getting an MRI, and what exactly will you be looking for on the scan?
  • At what age should we transition from 'growth monitoring' to 'malignancy screening' for my child?
  • Do you recommend a baseline 'whole-body' MRI, or do we only scan specific areas if they cause symptoms?

Questions for You

  • Have I noticed any old bumps that seem to be getting larger or changing shape recently?
  • Is there a specific pain that feels different from 'growing pains' or muscle soreness—perhaps a deep, persistent ache that doesn't go away with rest?
  • Do I feel more anxious about the risk of cancer than the physical symptoms themselves? (It's helpful to share this with your care team).

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference.

    Phan AQ, Pacifici M, Esko JD

    Connective tissue research 2018; (59(1)):85-98 doi:10.1080/03008207.2017.1394295.

    PMID: 29099240
  2. 2

    Hereditary multiple exostoses: an educational review.

    Rueda-de-Eusebio A, Gomez-Pena S, Moreno-Casado MJ, et al.

    Insights into imaging 2025; (16(1)):46 doi:10.1186/s13244-025-01899-6.

    PMID: 39982564
  3. 3

    Chondrosarcoma transformation in hereditary multiple exostoses: A systematic review and clinical and cost-effectiveness of a proposed screening model.

    Fei L, Ngoh C, Porter DE

    Journal of bone oncology 2018; (13()):114-122 doi:10.1016/j.jbo.2018.09.011.

    PMID: 30591865
  4. 4

    Osteochondromas: An Updated Review of Epidemiology, Pathogenesis, Clinical Presentation, Radiological Features and Treatment Options.

    Tepelenis K, Papathanakos G, Kitsouli A, et al.

    In vivo (Athens, Greece) 2021; (35(2)):681-691 doi:10.21873/invivo.12308.

    PMID: 33622860
  5. 5

    Hereditary multiple exostoses: A case report and literature review.

    Ha TH, Ha TMT, Nguyen Van M, et al.

    SAGE open medical case reports 2022; (10()):2050313X221103732 doi:10.1177/2050313X221103732.

    PMID: 35693925
  6. 6

    Identification of a new mutation in an Iranian family with hereditary multiple osteochondromas.

    Akbaroghli S, Balali M, Kamalidehghan B, et al.

    Therapeutics and clinical risk management 2017; (13()):15-19 doi:10.2147/TCRM.S111717.

    PMID: 28053536
  7. 7

    Osteoblastic Osteosarcoma Arising beneath an Osteochondroma in an 11-Year-Old Male with Multiple Hereditary Exostoses.

    Bukara E, Buteera AM, Karakire R, et al.

    Case reports in orthopedics 2018; (2018()):8280415 doi:10.1155/2018/8280415.

    PMID: 30123601
  8. 8

    Sarcomatous Transformation of Recurrent Scapular Osteochondroma in a Patient with the Hereditary Multiple Osteochondromas: A Case Report and Literature Review.

    Sajid S, Yousaf A, Nabi U, et al.

    Cureus 2019; (11(12)):e6308 doi:10.7759/cureus.6308.

    PMID: 31938600
  9. 9

    Multidetector computed tomography in the evaluation of hereditary multiple exostoses.

    Kwee RM, Fayad LM, Fishman EK, Fritz J

    European journal of radiology 2016; (85(2)):383-91.

    PMID: 26781144
  10. 10

    Investigating possible predictors of malignant transformation of osteochondroma: a retrospective cohort study with an illustrative case report.

    Hederick LL, Goh MH, Ibáñez-Navarro A, et al.

    Skeletal radiology 2026; doi:10.1007/s00256-026-05162-x.

    PMID: 41670645
  11. 11

    Secondary peripheral chondrosarcoma in multiple osteochondromas: a retrospective single-institution case series.

    Gnoli M, Gambarotti M, Righi A, et al.

    Orphanet journal of rare diseases 2024; (19(1)):63 doi:10.1186/s13023-023-03006-8.

    PMID: 38351015

This page provides educational information about malignant transformation in multiple osteochondromas. Always consult your orthopedic specialist for personalized monitoring and to evaluate any new symptoms or changes.

Stay up to date

Get notified when new research about Multiple osteochondromas is published.

No spam. Unsubscribe anytime.